Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

MANAGEMENT OF CONGESTIVE FAILURE

MANAGEMENT OF CONGESTIVE FAILURE This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: —The paper "Management of Congestive Failure" by D. A. Rytand, M.D., is too misleading in respect to the use of oxygen in cardiac failure to allow it to stand without question.Oxygen therapy is among the most valuable agents in the treatment of chronic cor pulmonale. When administered in small and gradually increased oxygen concentrations, the adverse effects of abrupt inhalation of high concentrations are generally prevented, as has been repeatedly emphasized since 1938. The use of 100% oxygen has not been advocated by any responsible investigator for the treatment of pulmonary emphysema, with or without cor pulmonale.The value of 40 to 50% oxygen in the treatment of left ventricular failure in cases of hypertensive and coronary artery disease was also established in the studies of Richards and the author, in which it was shown that relief of dyspnea was accompanied by a decrease in the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png A.M.A. Archives of Internal Medicine American Medical Association

MANAGEMENT OF CONGESTIVE FAILURE

A.M.A. Archives of Internal Medicine , Volume 95 (1) – Jan 1, 1955

MANAGEMENT OF CONGESTIVE FAILURE

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: —The paper "Management of Congestive Failure" by D. A. Rytand, M.D., is too misleading in respect to the use of oxygen in cardiac failure to allow it to stand without question.Oxygen therapy is among the most valuable agents in the treatment of chronic cor pulmonale. When administered in small and gradually increased...
Loading next page...
 
/lp/american-medical-association/management-of-congestive-failure-2tkbrgxBMa

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1955 American Medical Association. All Rights Reserved.
ISSN
0888-2479
DOI
10.1001/archinte.1955.00250070190024
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: —The paper "Management of Congestive Failure" by D. A. Rytand, M.D., is too misleading in respect to the use of oxygen in cardiac failure to allow it to stand without question.Oxygen therapy is among the most valuable agents in the treatment of chronic cor pulmonale. When administered in small and gradually increased oxygen concentrations, the adverse effects of abrupt inhalation of high concentrations are generally prevented, as has been repeatedly emphasized since 1938. The use of 100% oxygen has not been advocated by any responsible investigator for the treatment of pulmonary emphysema, with or without cor pulmonale.The value of 40 to 50% oxygen in the treatment of left ventricular failure in cases of hypertensive and coronary artery disease was also established in the studies of Richards and the author, in which it was shown that relief of dyspnea was accompanied by a decrease in the

Journal

A.M.A. Archives of Internal MedicineAmerican Medical Association

Published: Jan 1, 1955

There are no references for this article.